Sialidase [EC 3.2.1.18] catalyzes the removal of sialic acid residues in sialoglycoconjugates, and this reaction is associated with the many important biological reactions, such as survival of sialoglycoconjugates,1) antigenic expression2) and recognition by receptors.3) It is known that the serum sialic acid level changes in several diseases, such as inflammations, infections, cancers and rheumatism.4) In order to elucidate the role of sialic acid residues in these diseases, it is necessary to investigate their turnover. Sialidase activity has been studied mainly in animal tissues such as rat liver,5) pig brain,6) rat heart:7) rabbit spermatozoal acrosomes,8) rabbit endometrium,9) cultured human skin fibroblasts,10) human liver,11) human brain12) and human placenta,13) but only limited information is available on the mouse liver enzyme. Samollow et al. identified two kinds of sialidase activity for 4-methylumbelliferyl-x-D-N-acetylneuraminate (4-MU-NeuAc) in the mouse liver extract by cellulose acetate electrophoresis,14) but little information on the general properties and substrate specificity has been reported.
This report describes preliminary investigations on the general properties and substrate specificity of mouse liver sialidases, and a partial purification of the major sialidase activity in the lysosomal fraction. centrifugation at 15000 x g, approximately 72% of the original activity toward sialyllactose and 62% of that toward 4-MU-NeuAc were solubilized in the resultant supernatant (Table III) while 20% of the activity toward sialyllactose and 4% of that toward 4-MU-NeuAc remained in the pellet. The supernatant was further fractionated with ammonium sulfate, and the precipitate formed at 60% saturation exhibited 68% of the original activity toward sialyllactose and 27% toward 4-MU-NeuAc, while the supernatant showed little activity toward either substrate. This precipitate was soluble in the buffer but a part of the activity was insolubilized during the dialysis. The soluble enzyme recovered from the dialysate was purified 9.7-fold (toward sialyllactose) and 5.5-fold (toward 4-MU-NeuAc) from the lysosomal pellet (Table  III) . The soluble enzyme was further purified by DEAE-cellulose column chromatography. The sialidase activity emerged from the column as unadsorbed and adsorbed fractions. Recently, the human placental sialidase was partially purified by Verheijen et al.,13b) who showed that it exists as a complex with fl-galactosidase. In the present case, most of thefigalactosidase activity emerged as the unadsorbed fraction from the DEAE-cellulose column, applied to a Sephadex G-200 column, the sialidase activity was eluted as a single peak near the void volume (data not shown).
When the DEAE-cellulose adsorbed fraction was reacted with Con A and then subjected to Sephadex G-200 affinity chromatography, the sialidase activity was mainly detected in the Sephadex G-200 unadsorbed fraction. This Sephadex G-200 unadsorbed fraction was further purified by HPLC, and sialidase activity toward 4-MU-NeuAc was purified as a single protein peak. This purified enzyme showed the same retention time as the major 4-MUNeuAc sialidase, as shown in Fig. 2 , but the specific activity was decreased because of the lability of this sialidase.
Discussion
The subcellular distribution of mammalian sialidase has been studied in human skin fibroblasts,'" rat liver5a,b) and human liver.11a) In rat liver, sialidase activity is localized in cytoso1,5e) plasma membrane,") Golgi apparatus') and lysosomes.5a,b,e') Miyagi and Tsuiki also detected sialidase activity in the lysosomal, microsomal and cytosolic fractions from rat liver.5f,g) When the lysosomal fraction was solubilized by hypotonic disruption followed by ammonium sulfate precipitation, the resulting soluble enzyme was much more active against oligosaccharides and glycopeptides but inactive against glycoproteins and glycolipids in comparison with the lysosomal fraction, which is active against glycoproteins and glycolipids in addition to oligosaccharides and glycopeptides. Miyagi and Tsuiki reported that rat liver lysosomes contain at least two kinds of sialidase, one located in the intralysosomal space and the other in the lysosomal membrane.5f) In mouse liver, it was observed that the undisrupted pellet in the lysosomal fraction was active toward gangliosides (T. Nagai and H. Yamada, unpublished observation). They also reported that protease inhibitors markedly reduced the rat liver intralysosomal sialidase activity toward glycoproteins, and suggested that fragmentation of the protein core by protease may be prerequisite to glycoproteins becoming substrates of this enzyme.5f) In the case of mouse liver lysosomal sialidase, it was expected that The mouse liver microsomal fraction preferentially hydrolyzed bovine submaxillary mucin, which is known to have 9-O-acetylated sialic acid residues.25) Rat liver partially purified intralysosomal and purified cytosolic sialidases and human placental purified sialidase were incapable of hydrolyzing bovine submaxillary mucin.5f,g,13d) Since sialate-0-acetylesterase activity has been detected in mammalian and human livers when determined with 4-O-acetyl-and 9-O-acetylsialic acid as substrates,11a,26) it was expected that the microsomal sialidase would hydrolyze bovine submaxillary mucin after the removal of Oacetyl groups by sialate-O-acetylesterase. However, the present result indicated that the microsomal sialidases in mouse liver are able to hydrolyze O-acetylated sialic acid residues, because when the reaction product formed from bovine submaxillary mucin by the mouse microsomal sialidase was saponified before the TBA reaction, the absorbance in the TBA reaction was greatly increased (T. Nagai and H. Yamada, unpublished observation).
Miyagi and Tsuiki reported that lysosomal soluble sialidase of rat liver emerged from Sephadex G-200 at the void volume in the absence of KC1, but when the enzyme recovered from the carboxymethyl (CM)-cellulose column was rechromatographed on Sephadex G-200 in the presence of 0.3 M KC1, four peaks of sialidase activity were found, and the Mr of the slowest (the major) peak was estimated to be 60000.5f) On the other hand, Hiraiwa et al. reported that the human placental soluble sialidase was eluted near the void volume on HPLC in the presence of 0.1 M NaC1.13c,d) The molecular weight of the lysosomal soluble sialidase from mouse liver was estimated to be 680000 by HPLC, and this molecular weight did not change on HPLC even in the presence of 0.1 M NaCl. These results indicated that the molecular weight of mouse liver lysosomal soluble sialidase was higher than that of the rat liver lysosomal sialidase, but the possibility that this enzyme forms an aggregate could not be ruled out.
Verheijen et al. reported that sialidase and fl-galactosidase are not separable and that the two enzymes are present as a complex in human placental13b) and bovine testis.27) However, Hiraiwa et al. recently showed that these two enzymes in human placenta were separable by HPLC.13c.d) The present study confirmed that fl-galactosidase and sialidase in mouse liver are separable by HPLC. When this soluble lysosomal fraction was subjected to DEAE-cellulose column chromatography, most of the fl-galactosidase was separated from DEAE-celluloseadsorbed sialidase. Verheijen et al. also demonstrated that the activated and stabilized human lysosomal sialidase exists as a complex with fl-galactosidase.13b) The present results showed that lysosomal soluble sialidase activity in mouse liver became very unstable after purification by DEAE-cellulose column chromatography and HPLC, even when protease inhibitor was present during the purification step. It was expected that this lability of the partially purified . 
